Rekah Pharmaceutical Prod (XTAE:REKA) FFO


XTAE:REKA Rekah Pharmaceutical Prod Ltd XTAE:REKA
57 GF Score
Price ₪10.30
GF Value ₪13.05
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Rekah Pharmaceutical Prod FFO?

FFO (Funds from operations) only applies to REITs.

XTAE:REKA
57GF Score
Rekah Pharmaceutical Prod Ltd XTAE:REKA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rekah Pharmaceutical Prod (XTAE:REKA) Overvalued in 2026?

Based on GuruFocus' analysis, Rekah Pharmaceutical Prod stock appears to be undervalued. The current stock price of ₪10.30 is trading 21.1% below its estimated GF Value™ of ₪13.05. GuruFocus considers Rekah Pharmaceutical Prod to be Modestly Undervalued.

Key valuation signals for XTAE:REKA:

  • FFO:
  • GF Value™: ₪13.05 vs. price of ₪10.30 (21.1% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the XTAE:REKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rekah Pharmaceutical Prod Business Description

Address 30 Hamelacha Street, Holon, ISR
Rekah Pharmaceutical Prod Ltd is engaged in the manufacturing, importing, marketing, and distribution of pharmaceuticals and cosmetics. It primarily caters to the needs of hospitals, retirement homes, and national medical healthcare services.
57GF Score

Get the complete analysis for XTAE:REKA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪10.30
Price
₪13.05
GF Value